Metoprolol tartrate pharmacology
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Tartrate Pharmacology: Mechanism, Selectivity, and Metabolism
Metoprolol tartrate is a selective beta-1 adrenergic receptor blocker, commonly used to treat hypertension, heart failure, and certain cardiac arrhythmias 7Koch-Weser1979. Its selectivity for beta-1 receptors means it primarily affects the heart, reducing heart rate and contractility, with less impact on beta-2 receptors found in the lungs and blood vessels 7Koch-Weser1979. This selectivity helps minimize respiratory side effects compared to non-selective beta-blockers.
Metoprolol undergoes extensive first-pass metabolism in the liver, primarily via the cytochrome P450 2D6 (CYP2D6) enzyme . The drug is available in both immediate-release (tartrate) and slow-release (SR) formulations, which influence its absorption and plasma concentration profiles .
Pharmacokinetics: Absorption, Distribution, and Elimination
After oral administration, metoprolol tartrate is rapidly absorbed, but its bioavailability is reduced due to significant first-pass hepatic metabolism Regårdh2009Ela2016. The elimination half-life of metoprolol tartrate is about 4 hours in healthy adults . The drug and its metabolites are primarily excreted via the kidneys, with only a small fraction of unchanged drug found in urine Regårdh2009Quarterman1981.
Slow-release formulations of metoprolol tartrate produce lower peak plasma concentrations and delay the time to reach peak levels compared to immediate-release tablets, but the overall exposure (AUC) is similar between the two forms . Rectal administration of metoprolol tartrate has also been shown to increase bioavailability and produce a faster and greater reduction in blood pressure and heart rate compared to oral tablets, likely due to avoidance of first-pass metabolism .
Pharmacodynamics: Cardiovascular Effects and Clinical Use
Metoprolol tartrate reduces heart rate and blood pressure by blocking beta-1 adrenergic receptors in the heart Regårdh2009Yongha2015Koch-Weser1979. The drug’s effect on exercise heart rate and blood pressure declines at a constant rate after absorption, with a 50% reduction in maximum effect occurring about 8 hours after dosing . The relationship between plasma concentration and effect is linear for immediate-release tablets .
Clinically, metoprolol tartrate is effective and safe for treating conditions like hypertension and dilated cardiomyopathy, improving heart function and reducing adverse events compared to standard therapy . It is also used intravenously for acute cardiac indications 710.
Influence of Age, Genetics, and Formulation on Metoprolol Pharmacology
Age has a modest effect on metoprolol pharmacokinetics. Elderly patients may have higher concentrations of certain active metabolites, but the overall impact on drug levels and effects is less pronounced than with many other drugs . Genetic differences in CYP2D6 enzyme activity can significantly affect metoprolol metabolism. Poor and intermediate metabolizers experience greater reductions in heart rate, but blood pressure response and adverse effect rates are not significantly different across genetic groups .
Comparative Pharmacology: Metoprolol Tartrate vs. Other Beta-Blockers
Metoprolol tartrate is less complex in its receptor antagonism compared to agents like carvedilol, which block multiple adrenergic receptors and may offer additional benefits in heart failure . However, direct clinical comparisons between optimal doses of metoprolol tartrate and carvedilol are limited .
Conclusion
Metoprolol tartrate is a selective beta-1 blocker with well-characterized pharmacokinetics and pharmacodynamics. Its effects are influenced by formulation, route of administration, age, and genetic factors affecting metabolism. The drug is effective and generally well-tolerated for cardiovascular conditions, with its selectivity offering advantages over non-selective beta-blockers.
Sources and full results
Most relevant research papers on this topic